Sage Therapeutics
SAGE
#7392
Rank
NZ$0.59 B
Marketcap
$9.65
Share price
-3.03%
Change (1 day)
-72.20%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2024 (TTM): -NZ$0.55 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2023 the company made an earning of -NZ$0.97 Billion a decrease over its 2022 earnings that were of -NZ$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.55 Billion-42.76%
2023 -NZ$0.97 Billion1.63%
2022 -NZ$0.95 Billion16.36%
2021 -NZ$0.82 Billion-175.55%
2020 NZ$1.07 B-189.1%
2019 -NZ$1.21 Billion82.43%
2018 -NZ$0.67 Billion38.04%
2017 -NZ$0.48 Billion69.9%
2016 -NZ$0.29 Billion68.25%
2015 -NZ$0.17 Billion179.48%
2014 -NZ$59.97 Million84.98%
2013 -NZ$32.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$73.38 Million-87.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$63.24 M-110.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B-251.82%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-NZ$0.11 Billion-82.82%๐Ÿ‡บ๐Ÿ‡ธ USA